Spanish guidelines for the management of autosomal dominant polycystic kidney disease

作者：Ars Elisabet; Bernis Carmen; Fraga Gloria; Martinez Victor; Martins Judith; Ortiz Alberto; Carlos Rodriguez Perez Jose; Sans Laia; Torra Roser^*

来源：Nephrology Dialysis Transplantation, 2014, 29(suppl 4): 95-105.

DOI：10.1093/ndt/gfu186

• ADPKD
• autosomal dominant polycystic kidney disease
• guidelines
• recommendations
• management

Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent cause of genetic renal disease and accounts for 6-10% of patients on renal replacement therapy (RRT). Very few prospective, randomized trials or clinical studies address the diagnosis and management of this relatively frequent disorder. No clinical guidelines are available to date. This is a consensus statement presenting the recommendations of the Spanish Working Group on Inherited Kidney Diseases, which were agreed to following a literature search and discussions. Levels of evidence found were C and D according to the Centre for Evidence-Based Medicine (University of Oxford). The recommendations relate to, among other topics, the use of imaging and genetic diagnosis, management of hypertension, pain, cyst infections and bleeding, extra-renal involvement including polycystic liver disease and cranial aneurysms, management of chronic kidney disease (CKD) and RRT and management of children with ADPKD. Recommendations on specific ADPKD therapies are not provided since no drug has regulatory approval for this indication.

• 出版日期2014-9